Brain Gene Expression of a Sporadic (icv-STZ Mouse) and a Familial Mouse Model (3xTg-AD Mouse) of Alzheimer's Disease

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Chen, Yanxing ^a,b   Tian, Zhu ^a,c   Liang, Zhihou ^b   Sun, Shenggang ^b   Dai, Chun ling ^a   Lee, Moon H ^a   LaFerla, Frank M ^d   Grundke Iqbal, Inge ^a   Iqbal, Khalid ^a   Liu, Fei ^a   Gong, Cheng Xin ^a  

^a NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID PRECURSOR PROTEIN; INSULIN; MAMMALIAN TARGET OF RAPAMYCIN; PRESENILIN; PROTEIN KINASE; STREPTOZOCIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN; BRAIN CORTEX; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSKELETON; DISEASE ASSOCIATION; DISEASE MODEL; DOWN REGULATION; FAMILIAL ALZHEIMER DISEASE; GENE EXPRESSION; GENE FUNCTION; GENETIC ASSOCIATION; GLUCOSE METABOLISM; HIPPOCAMPUS; MOUSE; MUTATION; NONHUMAN; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPORADIC ALZHEIMER DISEASE; SYNAPSE;

ALZHEIMER DISEASE; ANIMALS; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; DNA, COMPLEMENTARY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MICE; PRESENILIN-1; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STREPTOZOCIN; TRANSCRIPTOME;

MUS;

EID: 84870940064     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051432     Document Type: Article

References (59)

1. Finder VH, (2010) Alzheimer's disease: a general introduction and pathomechanism. J Alzheimers Dis 22Suppl 3: 5-19.
2. Association Association, (2012) 2012 Alzheimer's disease facts and figures. Alzheimers Dement 8: 131-168.
3. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, et al. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39: 409-421.
4. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM, (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24: 1063-1070.
5. Mastrangelo MA, Bowers WJ, (2008) Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice. BMC Neurosci 9: 81.
6. Iqbal K, Grundke-Iqbal I, (2005) Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies. Acta Neuropathol 109: 25-31.
7. Heiss WD, Szelies B, Kessler J, Herholz K, (1991) Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann N Y Acad Sci 640: 65-71.
8. Gong CX, Liu F, Grundke-Iqbal I, Iqbal K, (2006) Impaired brain glucose metabolism leads to Alzheimer neurofibrillary degeneration through a decrease in tau O-GlcNAcylation. J Alzheimers Dis 9: 1-12.
9. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX, (2011) Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes. J Pathol 225: 54-62.
10. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, et al. (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease-is this type 3 diabetes? J Alzheimers Dis 7: 63-80.
11. de la Monte SM, Wands JR, (2008) Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol 2: 1101-1113.
12. Deng Y, Li B, Liu Y, Iqbal K, Grundke-Iqbal I, et al. (2009) Dysregulation of insulin signaling, glucose transporters, O-GlcNAcylation, and phosphorylation of tau and neurofilaments in the brain: Implication for Alzheimer's disease. Am J Pathol 175: 2089-2098.
13. Grunblatt E, Salkovic-Petrisic M, Osmanovic J, Riederer P, Hoyer S, (2007) Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein. J Neurochem 101: 757-770.
14. Salkovic-Petrisic M, Tribl F, Schmidt M, Hoyer S, Riederer P, (2006) Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway. J Neurochem 96: 1005-1015.
15. Salkovic-Petrisic M, Osmanovic-Barilar J, Bruckner MK, Hoyer S, Arendt T, et al. (2011) Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J Neural Transm 118: 765-772.
16. Arendt T, (2009) Synaptic degeneration in Alzheimer's disease. Acta Neuropathol 118: 167-179.
17. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, et al. (1991) Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30: 572-580.
18. Raynaud F, Marcilhac A, (2006) Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J 273: 3437-3443.
19. Barnett A, Brewer GJ, (2011) Autophagy in aging and Alzheimer's disease: pathologic or protective? J Alzheimers Dis 25: 385-394.
20. Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I, (2009) Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118: 53-69.
21. Vosler PS, Brennan CS, Chen J, (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 38: 78-100.
22. Liu F, Grundke-Iqbal I, Iqbal K, Oda Y, Tomizawa K, et al. (2005) Truncation and activation of calcineurin A by calpain I in Alzheimer disease brain. J Biol Chem 280: 37755-37762.
23. Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, et al. (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30: 1104-1113.
24. Zeidan Q, Hart GW The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 123: 13-22.
25. Love DC, Hanover JA, (2005) The hexosamine signaling pathway: deciphering the "O-GlcNAc code". Sci STKE 2005: re13.
26. de la Monte SM, (2012) Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease. Curr Alzheimer Res 9: 35-66.
27. Gerozissis K, (2008) Brain insulin, energy and glucose homeostasis; genes, environment and metabolic pathologies. Eur J Pharmacol 585: 38-49.
28. de la Monte SM, (2009) Insulin resistance and Alzheimer's disease. BMB Rep 42: 475-481.
29. Rasgon NL, Kenna HA, Wroolie TE, Kelley R, Silverman D, et al. (2011) Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease. Neurobiol Aging 32: 1942-1948.
30. Swiech L, Perycz M, Malik A, Jaworski J, (2008) Role of mTOR in physiology and pathology of the nervous system. Biochim Biophys Acta 1784: 116-132.
31. Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, et al. (2005) mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J Neurochem 94: 215-225.
32. Reddy PH, McWeeney S, (2006) Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models. Neurobiol Aging 27: 1060-1077.
33. Plaschke K, Kopitz J, Siegelin M, Schliebs R, Salkovic-Petrisic M,et al. Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice. J Alzheimers Dis 19: 691-704.
34. Nizzari M, Thellung S, Corsaro A, Villa V, Pagano A, et al. (2012) Neurodegeneration in Alzheimer disease: role of amyloid precursor protein and presenilin 1 intracellular signaling. J Toxicol 2012: 187297.
35. Hutton M, Hardy J, (1997) The presenilins and Alzheimer's disease. Hum Mol Genet 6: 1639-1646.
36. Das HK, (2008) Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease. Front Biosci 13: 822-832.
37. Chen Q, Nakajima A, Choi SH, Xiong X, Tang YP, (2008) Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse. J Neurosci Res 86: 1615-1625.
38. Shen J, Kelleher RJ, 3rd (2007) The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci U S A 104: 403-409.
39. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, et al. (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42: 23-36.
40. Zhang D, Zhang C, Ho A, Kirkwood A, Sudhof TC, et al. (2010) Inactivation of presenilins causes pre-synaptic impairment prior to post-synaptic dysfunction. J Neurochem 115: 1215-1221.
41. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, et al. (2009) Presenilins are essential for regulating neurotransmitter release. Nature 460: 632-636.
42. Miners JS, Barua N, Kehoe PG, Gill S, Love S, (2011) Abeta-degrading enzymes: potential for treatment of Alzheimer disease. J Neuropathol Exp Neurol 70: 944-959.
43. Blanchard J, Wanka L, Tung YC, Cardenas-Aguayo Mdel C, LaFerla FM, et al. (2010) Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Abeta and tau pathologies in 3xTg-AD mice. Acta Neuropathol 120: 605-621.
44. Weinstock M, Shoham S, (2004) Rat models of dementia based on reductions in regional glucose metabolism, cerebral blood flow and cytochrome oxidase activity. J Neural Transm 111: 347-366.
45. Katzman R, Saitoh T, (1991) Advances in Alzheimer's disease. FASEB J 5: 278-286.
46. Saura CA, Valero J, (2011) The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev Neurosci 22: 153-169.
47. Muller M, Cardenas C, Mei L, Cheung KH, Foskett JK, (2011) Constitutive cAMP response element binding protein (CREB) activation by Alzheimer's disease presenilin-driven inositol trisphosphate receptor (InsP3R) Ca2+ signaling. Proc Natl Acad Sci U S A 108: 13293-13298.
48. Herrera DG, Robertson HA, (1996) Activation of c-fos in the brain. Prog Neurobiol 50: 83-107.
49. Lyons MR, West AE, (2011) Mechanisms of specificity in neuronal activity-regulated gene transcription. Prog Neurobiol 94: 259-295.
50. Brooks WM, Lynch PJ, Ingle CC, Hatton A, Emson PC, et al. (2007) Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease. Brain Res 1127: 127-135.
51. Ciavardelli D, Silvestri E, Del Viscovo A, Bomba M, De Gregorio D, et al. (2010) Alterations of brain and cerebellar proteomes linked to Abeta and tau pathology in a female triple-transgenic murine model of Alzheimer's disease. Cell Death Dis 1: e90.
52. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX, (2009) Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease. J Neurochem 111: 242-249.
53. Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX, (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582: 359-364.
54. El Messari S, Leloup C, Quignon M, Brisorgueil MJ, Penicaud L, et al. (1998) Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. J Comp Neurol 399: 492-512.
55. Bakirtzi K, Belfort G, Lopez-Coviella I, Kuruppu D, Cao L, et al. (2009) Cerebellar neurons possess a vesicular compartment structurally and functionally similar to Glut4-storage vesicles from peripheral insulin-sensitive tissues. J Neurosci 29: 5193-5201.
56. Grillo CA, Piroli GG, Hendry RM, Reagan LP, (2009) Insulin-stimulated translocation of GLUT4 to the plasma membrane in rat hippocampus is PI3-kinase dependent. Brain Res 1296: 35-45.
57. Cardoso S, Correia S, Santos RX, Carvalho C, Santos MS, et al. (2009) Insulin is a two-edged knife on the brain. J Alzheimers Dis 18: 483-507.
58. Baker LD, Cross DJ, Minoshima S, Belongia D, Watson GS, et al. (2011) Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes. Arch Neurol 68: 51-57.
59. Rossini AA, Like AA, Chick WL, Appel MC, Cahill GF Jr, (1977) Studies of streptozotocin-induced insulitis and diabetes. Proc Natl Acad Sci U S A 74: 2485-2489.